Calendar

Cloudflare’s reported Q2 2026 revenue growth and a $736.8M Q3 revenue consensus provide a credible business backdrop, but the stock fell sharply into the event: it lost roughly 15.5% from Oct. 26 to Oct. 30, including a high-volume down day. Required positive tape and estimate-upside signals are not supported.

ABNB has a small positive whisper-versus-consensus gap and recent company guidance describes strong revenue growth, but the guidance midpoint is slightly below the checked revenue consensus. The stock fell about 4.4% over five sessions, had no close above the 0.75 close-location threshold in the latest three sessions, and no confirmed 1.5x volume session; it does not qualify despite a supportive XLY tape.

EOG has upward EPS estimate revisions, a credible Q3 consensus, and a strong Oct. 30 close, but available checks did not establish positive revenue revisions or a recent >1.5x-volume accumulation day. The company has scheduled its Q3 results for Nov. 5 after close; its IR page separately lists a Nov. 6 results call.

Lumentum's September-quarter EPS estimate rose from $4.21 to $4.22 over the last month, and its prior company guidance midpoint for $1.25B revenue is in line with reported consensus; management cited accelerating AI-driven optical demand and the stock advanced sharply over the preceding five sessions. However, the late-week reversal and lack of a verified normal-volume comparator temper the setup, while valuation and execution risks remain material.

Simon has positive, though non-uniform, estimate momentum: checked consensus showed EPS up 1.74% and revenue up 3.69% over three months, and its latest reported quarter showed 96.0% occupancy, higher retailer sales, and raised full-year FFO guidance. The stock gained about 2.4% over five sessions and closed near the top of its Oct 30 range, but a normal-volume comparison was unavailable and its recent earnings history is uneven.

DVN has positive near-term estimate revisions, rising revenue expectations, four recent EPS beats per Zacks, and an official Nov. 5 reporting date; the stock also strengthened into the event. However, earnings-whisper EPS is below some consensus figures and the shares lagged the energy sector over the past month, while commodity exposure and transaction execution leave meaningful uncertainty.

Earnings Whispers reports a $1.48 whisper against $1.39 consensus, while the prior quarter had strong reported growth; however, no reliable pre-event revenue-revision, verified close-location, or volume-accumulation evidence was found for this screen, and the supplied latest close does not establish recent strength. The positive whisper alone is insufficient for qualification.

ED's reported date and consensus figures were available, and the recent close rose with XLU supportive; Con Edison had reaffirmed its 2026 adjusted EPS guidance. But no positive EPS revision, ESP, whisper, or revenue-upside signal was verified, and none of the last three checked sessions closed in the upper quarter of its range.

A pre-event Zacks article says the estimate-revision combination points toward a likely EPS beat, and recent annualized recovery expectations offer a possible cyclical catalyst. However, exact revision and current-quarter revenue consensus/upside evidence was not verifiable in the checked results, while Oct. 30 brought a high-volume 4.66% selloff and a weak close; it fails the required tape confirmation.

Live Nation has strong operating indicators ahead of the report: the latest available filing said 2026 event ticket sales were pacing 11% higher and deferred revenue reached a second-quarter record, while the stock recovered into Oct. 30 on a large-volume up day. But current-quarter revenue consensus estimates varied across checked providers and no positive EPS revision/ESP/whisper was verified; score remains below the required threshold.

The supplied Nov. 5 date conflicts with checked earnings sources: Earnings Whispers and MarketBeat indicate Nov. 4, while another estimate page shows Nov. 5 and cautions the date may move. Consensus estimates exist, but no positive revisions or required tape confirmation were established; reject on unconfirmed event date and incomplete signals.

MRNA has a modestly favorable EPS revision snapshot and a recent high-volume rebound, but the checked calendar sources describe Nov. 6 as estimated rather than company-confirmed, and no positive revenue revision or upside indicator was verified. The Oct. 22 melanoma-trial data leak coincided with a 17.57% drop and unusually high volume, leaving a volatile, event-driven tape.

Record Q2 fundraising and 20% fee-related-earnings growth, alongside a rising recent share price and several analyst target cuts, create a constructive but mixed backdrop. The checked sources support EPS and revenue consensus, but do not establish positive estimate revisions or an upside surprise signal; recent volume also falls short of a verified accumulation trigger.

Humana's primary IR estimate table showed near-flat Q3 EPS revisions and a credible consensus source provides EPS and revenue estimates, but the stock weakened into the event and underperformed the rising XLV. Medical-cost and Medicare policy uncertainty remain material, while recent tape did not confirm accumulation.

Vistra has a company-confirmed Nov. 6 report date and a strongly positive 30-day Q3 EPS revision, alongside long-term power-demand catalysts. However, shares declined about 5.4% from Oct. 26 through Oct. 30, recent closes were weak in their daily ranges, and the latest quarter missed consensus materially. Positive revisions alone do not offset the poor pre-event tape and limited recent execution evidence.

Early T+1 evidence is mixed-positive: a modest EPS beat and better Q3 funding and credit metrics came with reduced 2026 balance-sheet and net-interest-income growth outlooks. A quote retrieved for October 20 at 13:32 UTC was $75.08, about 2.0% above the packet's October 19 $73.63 anchor; that early move is not a closing reaction or proof the outlook was well received. Verified post-print analyst revisions and earnings-call commentary were not yet available. Numeric sentiment, options, short-interest and employee measures were not supplied; zeros mean unavailable, not neutral. Consensus EPS source: https://finance.yahoo.com/markets/stocks/articles/western-alliance-q3-earnings-snapshot-203409695.html

The October 19 close of $245.17 predates the after-hours release. Shares fell roughly 5% in early October 20 trading as the EPS and guidance miss outweighed record shipments; a full-session reaction was unavailable at this cutoff. [Premarket coverage](https://finance.yahoo.com/markets/stocks/articles/steel-dynamics-shares-fall-5-103343450.html). Goldman reiterated its $299 target after results, while Barclays' raise to $285 was a pre-earnings preview, not a post-print upgrade. [Goldman coverage](https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-steel-dynamics-stock-rating-on-mixed-q3-results-93CH-4959262); [Barclays timing](https://www.tipranks.com/news/the-fly/steel-dynamics-price-target-raised-to-285-from-272-at-barclays-thefly-news). The scheduled earnings call and broader estimate revisions remained to be assessed. The prior baseline was constructive, but the deterministic delta prior turned negative with a material thesis-change score of 0.685; strong filing evidence does not erase near-term execution risk.

The packet's positive deterministic prior reflects a potentially important earnings trigger, but the trigger lacks a confirmed October 19 release. Zero-valued sentiment fields mean unavailable, not neutral measurements. No reliable post-release price reaction, consensus surprise or analyst target revision was found; do not interpret their absence as positive. The $114.75 anchor predates the proposed follow-up.

The October 19 anchor is a pre-release reference, not a measured post-earnings reaction. The company IR page still lists Q2 as the latest results, so Q3 surprise, market reaction and post-print analyst revisions are unavailable. The packet's unrelated Plumas Bancorp article is excluded. Low coverage and the unverified earnings date keep this a monitoring view despite the deterministic prior's stronger evidence-quality score and neutral direction.

Initial news is mixed-to-negative: EPS missed the cited consensus and credit quality deteriorated, partly offset by stable net interest income and the declared dividend. The $65.78 anchor is dated before the after-close release, so it cannot establish the post-print move. No reliable full-session reaction or post-print analyst revisions were found at this early T+1 point; zero-valued sentiment fields denote unavailable measurements, not neutral readings.

The October 19 release followed the close. FNB traded at $17.33, up 2.15% from the $16.96 anchor, at 9:38 a.m. ET on October 20; this is an early intraday reaction, not a closing verdict or evidence of why the stock moved. Verified post-print analyst revisions were unavailable. Strong primary-source evidence warrants updating the April baseline, but the revenue miss and narrower guidance keep the thesis at Hold rather than a bullish rerating. Sentiment metrics other than qualitative headline buzz were unavailable; zero values above are placeholders, not measured neutral readings. [Price history](https://stockanalysis.com/stocks/fnb/history/) [Q3 earnings release](https://www.fnb-online.com/about-us/newsroom/press-releases/2026/261019-fnb-corporation-reports-third-quarter)